Michael Förster’s Post

ICYMI: Todd M. Morgan, MD, University of Michigan, sat down with Zachary Klaassen, Georgia Cancer Center, to discuss a post-prostatectomy model that can stratify risk in prostate cancer patients who have had biochemical recurrence. The discussion, part of a new video with UroToday + GU OncToday, underscores the shifting paradigm in #prostatecancer management towards integrating sophisticated biomarkers with traditional treatment modalities, reflecting significant advancements in the #precisionmedicine approach within urologic #oncology. ▶️ Watch the full video: https://bit.ly/4dNyCQ3

Early detection of lung cancer through personalized screening with low-dose #CT imaging is significantly decreasing #lungcancer mortality. Since lung cancer screening requires frequent CT scans, the cumulative dose over a patient’s screening lifetime must be considered.  To minimize dose, our unique Tin Filter technology cuts out lower energies while optimizing diagnostic image quality. Download the white paper to learn more about the distinct benefits of this technology in the detection of pulmonary nodules:  https://lnkd.in/eWMu3sqN You think ahead. We innovate ahead. #strongportfolio #oncology

🔍 Want to know more about #androgen signaling combinations for #mCRPC? 👉 Check out this research from Ana Aparicio, MD, of MD Anderson Cancer Center and colleagues investigating #ipilimumab plus #AAPA. 📚 Read More:

Early detection of lung cancer through personalized screening with low-dose #CT imaging is significantly decreasing #lungcancer mortality. Since lung cancer screening requires frequent CT scans, the cumulative dose over a patient’s screening lifetime must be considered. To minimize dose, our unique Tin Filter technology cuts out lower energies while optimizing diagnostic image quality. Download the white paper to learn more about the distinct benefits of this technology in the detection of pulmonary nodules: https://lnkd.in/d5YuWAsC You think ahead. We innovate ahead. #strongportfolio #oncology

Did you know that Australians on average will benefit from products, services and technologies delivered by ANSTO at least twice in their lifetime. It could be a simple scan or a more complex treatment for Cancer using Nuclear Medicine. Your ANSTO is recognised globally as a leading research organisations in this area and NCEPT is another example of Australian scientists discovering and developing new technologies to save lives, right here in Australia. #ANSTO #FUTUREMADEINAUSTRALIA #NCEPT

Early detection of lung cancer through personalized screening with low-dose #CT imaging is significantly decreasing #lungcancer mortality. Since lung cancer screening requires frequent CT scans, the cumulative dose over a patient’s screening lifetime must be considered.  To minimize dose, our unique Tin Filter technology cuts out lower energies while optimizing diagnostic image quality. Download the white paper to learn more about the distinct benefits of this technology in the detection of pulmonary nodules:  https://lnkd.in/e9s3rQ-5 You think ahead. We innovate ahead. #strongportfolio #oncology

Early detection of lung cancer through personalized screening with low-dose #CT imaging is significantly decreasing #lungcancer mortality. Since lung cancer screening requires frequent CT scans, the cumulative dose over a patient’s screening lifetime must be considered.  To minimize dose, our unique Tin Filter technology cuts out lower energies while optimizing diagnostic image quality. Download the white paper to learn more about the distinct benefits of this technology in the detection of pulmonary nodules: https://lnkd.in/dk-cKpHE You think ahead. We innovate ahead. #strongportfolio #oncology

🌟 𝗡𝗲𝘄 𝗘𝗽𝗶𝘀𝗼𝗱𝗲 𝗔𝗹𝗲𝗿𝘁: "𝗪𝗵𝗮𝘁’𝘀 𝗡𝗲𝘄 𝗗𝗼𝗰? 𝗶𝗻 𝗟𝘂𝗻𝗴 𝗖𝗮𝗻𝗰𝗲𝗿" 🌟   In the latest episode of 'What's New in Doc?' in Lung Cancer, Prof Johan Vansteenkiste (University Hospitals Leuven) and Prof Mariana Brandao (Institut Jules Bordet) discuss the innovative drug tarlatamab, bringing hope to pretreated SCLC patients. 👇 Watch all WND Lung videos - link in the comments! #MediMix #LungCancer #Immunotherapy #Oncology #MedicalInnovation #Tarlatamab #ESMO2023

Experts on colorectal cancer brainstorm ways to optimize clinical research on ctDNA and discuss patient perceptions of ctDNA testing. https://lnkd.in/er28PAjf #crcsm #cancer #Oncology

WATCH: Expert oncologists reflect on the evolving treatment paradigm for KRAS-mutated mNSCLC w/ insight into data from #ESMO23, discussing targeted therapies and future perspectives in clinical practice. #oncology https://lnkd.in/eNrw_tyq